₹4481
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Rompost 250 Injection 1's belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, often called idiopathic thrombocytopenic purpura (ITP), is an immune disorder characterised by low platelet counts.
Rompost 250 Injection 1's contains 'Romiplostim,' which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Rompost 250 Injection 1's promotes platelet formation by activating the thrombopoietin receptor. Thereby, Rompost 250 Injection 1's helps treat immune thrombocytopenia effectively.
Rompost 250 Injection 1's will be administered by the healthcare professional. In some cases, Rompost 250 Injection 1's may cause common side effects like headache, joint pain, dizziness, trouble sleeping, muscle tenderness or weakness, pain in the arms and legs and indigestion. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Notify your doctor if you have allergic reactions to Rompost 250 Injection 1's or other medications. You must inform your doctor if you have leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or heart, kidney, or liver problems. Rompost 250 Injection 1's is not recommended during pregnancy unless indicated by the doctor. Rompost 250 Injection 1's may make you dizzy; hence drive or operate machinery only when you are alert. Rompost 250 Injection 1's is not recommended for use during breastfeeding.
Rompost 250 Injection 1's is used in the treatment of immune thrombocytopenia (an immune disorder characterised by low platelet counts). The detailed uses of Rompost 250 Injection 1's are as follows:
Rompost 250 Injection 1's contains 'Romiplostim' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune thrombocytopenia. Rompost 250 Injection 1's promotes platelet formation by activating the thrombopoietin receptor. Thereby, Rompost 250 Injection 1's helps treat immune thrombocytopenia effectively.
Caution
You are recommended not to consume alcohol along with Rompost 250 Injection 1's to avoid unpleasant side effects.
Caution
Rompost 250 Injection 1's is not recommended in pregnancy unless indicated by the doctor. Please consult your doctor if you are pregnant or planning to conceive.
Unsafe
Breast-feeding must be avoided during treatment with Rompost 250 Injection 1's. Please consult your doctor if you have any concerns.
Caution
Rompost 250 Injection 1's may cause dizziness. Hence, it is recommended not to drive or operate machinery until you are mentally alert.
Caution
Rompost 250 Injection 1's is not recommended particularly if you have a history of chronic liver disease/conditions. Please consult your doctor if you have any concerns
Caution
Limited information was available for the usage of Rompost 250 Injection 1's in patients suffering from kidney illness. Please consult your doctor if you have any concerns. Your doctor will prescribe only if the benefits outweigh the risks.
Caution
Rompost 250 Injection 1's is not recommended for children less than one year of age.
Caution
Rompost 250 Injection 1's should be administered with caution in patients with heart problems. Therefore, please talk to your doctor before receiving Rompost 250 Injection 1's.
Caution
Rompost 250 Injection 1's should be administered with caution in elderly patients due to an increased risk of side effects. Seek medical advice if you have any concerns.

Have a query?
Before beginning Rompost 250 Injection 1's, notify your doctor if you have had any allergic reactions to Rompost 250 Injection 1's or any other medications. You must notify your doctor if you have blood or bone marrow cancer (leukaemia), bleeding or clotting disorders, heart, kidney, or liver problems. Rompost 250 Injection 1's is not recommended during pregnancy unless indicated by the doctor. Rompost 250 Injection 1's may make you dizzy hence do not attempt to drive or operate machinery until you are physically stable and mentally alert. Rompost 250 Injection 1's should never be used to normalize platelet counts; Rompost 250 Injection 1's should only be used in ITP patients whose thrombocytopenia and clinical condition increase the risk of bleeding. Rompost 250 Injection 1's is not recommended for use during breastfeeding.
Drug-Drug Interactions: Rompost 250 Injection 1's may interact with anti-cancer medication (e.g. carfilzomib, ibritumomab) and medication used to treat myasthenia gravis (e.g. efgartigimod alfa).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Rompost 250 Injection 1's may interact with disease conditions like leukaemia, liver or kidney impairment.
Login/Sign Up
Login/Sign Up
RXAlkem Laboratories Ltd
₹3392.5
(₹3392.5 per unit)
RXZydus Cadila
₹3843.5
(₹3843.5 per unit)
RXIntas Pharmaceuticals Ltd
₹4109
(₹8218.0/ 1ml)
Rompost 250 Injection 1's belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
Rompost 250 Injection 1's contains Romiplostim, which promotes platelet formation by activating the thrombopoietin receptor. Thus Rompost 250 Injection 1's lowers the risk of bleeding episodes in diseases like immune thrombocytopenia and other associated conditions.
Immune thrombocytopenia is an autoimmune disorder in which the immune system misidentifies platelets as foreign bodies and destroys them. It can occur due to a virus, vaccination, or certain drugs. But the origin is unknown in the majority of cases.
Rompost 250 Injection 1's is only advised for patients who have not responded adequately to other treatments such as corticosteroids, immunoglobulins, or splenectomy.
Idiopathic thrombocytopenic purpura is typically diagnosed with blood tests such as complete blood count and antiplatelet-antibody test.
Rompost 250 Injection 1's is not approved to treat thrombocytopenia caused by Myelodysplastic syndrome (MDS) or any other cause of thrombocytopenia apart from chronic ITP.
Disclaimer
We provide you with authentic, trustworthy and relevant information